Eutropics Pharmaceuticals to Present Data on Personalized Diagnostic for AML Patient Management at American Society of Clinical Oncology 2013
5/16/2013 8:45:49 AM
More...
|
Eutropics Pharmaceuticals Signs $1.5 Million National Cancer Institute/SBIR Contract to Develop Companion Diagnostic for Guiding Multiple Myeloma Treatments
9/21/2012 11:04:59 AM
More...
|
Eutropics Pharmaceuticals Signs $1.5M NCI/SBIR Contract to Develop Companion Diagnostic for Guiding Multiple Myeloma Treatments
9/20/2012 11:10:10 AM
More...
|
Eutropics Pharmaceuticals Awarded National Cancer Institute Contract to Develop Companion Diagnostic for Guiding AML Treatments
9/19/2012 10:16:46 AM
More...
|
Eutropics Pharmaceuticals Receives U.S. Patent for Novel Diagnostic Method
5/8/2012 12:18:49 PM
More...
|